FDA Town Hall
June 23, 2026
29AB
Type: Super Session
Focus Area:
Science and Regulatory Innovation
Join us for a moderated discussion with the acting directors of the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA). Topics will include center priorities, staffing, and key initiatives.
Moderator
.jpg)
Speakers
Acting Director, Center for Drug Evaluation and Research (CDER)
U.S. Food and Drug Administration (FDA)
Acting Director, Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration (FDA)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}